MAPT and Alzheimer disease: NPs are widely used in the diagnosis and treatment of AD [183]; however, for successful results, several aspects must be considered, including the target-specific distribution and metabolism of NPs and the interactions between target molecules (Aβ/Tau/NFT) and NPs.